- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Photocure
Market Cap: NOK 1.3b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 50.20
7D
1.0%
1Y
-23.8%
Lytix Biopharma
Market Cap: NOK 557.0m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 8.60
7D
5.1%
1Y
25.0%
Nykode Therapeutics
Market Cap: NOK 542.1m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 1.67
7D
-12.3%
1Y
-89.1%
Navamedic
Market Cap: NOK 393.9m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.80
7D
0%
1Y
-36.8%